This activity will present ways in which the treatment paradigm for Dravet and Lennox-Gastaut syndromes is evolving to include not only seizure reduction but also an understanding of the caregiver burden and the impact of non-seizure symptoms.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://nexusmedx.motivelms.com/browse/preview/321
- Start Date: 2024-12-23 06:00:00
- End Date: 2024-12-23 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- Commercial Support: Source: Takeda Pharmaceuticals (Any division) - Amount: 104500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest